Is there more damage to come for Slater & Gordon Limited?

Slater & Gordon Limited (ASX:SGH) shares have crashed 42% over the last week and there are fears there could be more damage to come.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders of embattled legal eagle Slater & Gordon Limited (ASX: SGH) have watched helplessly over the last week as their once high-flying company has crashed from the inside out.

The shares plunged to a seven-month low of $3.50 on Monday, before ending the day 25% lower at $3.78. That represents an agonising 42% plunge since last Tuesday, and a 53% decline since its all-time high of $8.07 in April this year. There are two major issues currently weighing on the market's sentiment.

Quindell Plc

First, it was announced last week that the UK's Financial Conduct Authority would look into the activities of Quindell Plc, relating to comments made by Quindell during 2013 and 2014.

Slater & Gordon acquired the Professional Services Division (PSD) from Quindell for approximately $1.2 billion earlier this year – a deal that had many investors scratching their heads at the time – and it remains unclear just how that investigation could impact Slater & Gordon.

In an update to the market, Slater & Gordon acknowledged the public's concerns in relation to the accounting policies of Quindell prior to the acquisition, while it also said: "As the acquisition of PSD was structured as an acquisition of the PSD entities rather than its parent entities, Slater and Gordon is confident that it has no liability in relation to the ongoing investigations relating to Quindell."

The market wasn't so confident, selling the stock off heavily as a result.

ASIC Investigation

Yesterday, the situation went from bad to worse for Slater & Gordon shareholders after it was revealed that Australia's own financial watchdog, the Australian Securities and Investments Commission (ASIC), would conduct its own investigation into Slater & Gordon's relationship with accounting partner Pitcher Partners.

The company said: "Since Wednesday 24 June Slater and Gordon (SGH) (Company) has engaged proactively with [ASIC] following ASIC's routine review of Pitcher Partners' (PP) audit process of the Company. The Company asked ASIC to raise with it any queries it had as expeditiously as possible. The Company advised ASIC that it would fully cooperate and was eager to resolve all ASIC queries as soon as reasonably possible."

So far, two errors have been found and if analysis undertaken by VGI Partners is anything to go buy, more could still be hiding under the surface.

More to come?

As highlighted by the Fairfax press, VGI Partners believes that the purpose of the 40-odd acquisitions undertaken by Slater & Gordon may have been more about covering up poor organic growth than expanding its global dominance.

As noted by VGI, companies that operate under the Work in Progress (WIP) accounting method, such as Slater & Gordon, can theoretically recognise earnings before the cash is actually received despite the high level of judgement that is required in determining the likelihood of ever receiving that cash. As Fairfax puts it, "when is a dollar a dollar?"

Whether or not there are more accounting errors to be found remains uncertain, but the market's confidence has clearly been shattered with many choosing not to wait around to find out. Of course, the timing of these developments couldn't have been worse given the market's enormous uncertainty regarding the Greece debt 'tragedy', which has dragged the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) deep into the red in recent days.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »